Clinical Trial Update: Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy With Systemic Nabpaclitaxel-Gemcitabine Chemotherapy for Pancreatic Cancer Peritoneal Metastases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating combined Nab-paclitaxel pressurized intraperitoneal aerosol chemotherapy with systemic Nab-paclitaxel-gemcitabine for pancreat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Peritoneal Carcinomatosis

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)
• Nab-paclitaxel pressurized intraperitoneal aerosol chemotherapy

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Peritoneal Carcinomatosis, Pancreas Neoplasm | Phase 2 | Status: UNKNOWN